Natural flavoring complicated the quality test.
Following the publication of omega-3 product quality tests in its January 2012 issue, Consumer Reports is now retracting its conclusion that Nordic Naturals’ (Watsonville, CA) Ultimate Omega 180 product did not meet adequate freshness levels.
In its article “Fish-Oil Pills vs. Claims,” Consumer Reports stated that Nordic Naturals Ultimate Omega 180 tested for elevated levels of compounds that indicate spoilage. The publication then ran the following correction on its website:
“Upon further review, we have found that the industry-standard spoilage test we used cannot reliably detect spoilage in products with lemon oil, and we could not identify any current well-established methodology for doing so.”
Nordic Naturals CEO Joar Opheim says that the lemon flavoring of Ultimate Omega 180 appears to have created a false reading for anisidine, an indicatory of freshness. While there currently is no established methodology for testing flavored fish oils, Opheim says his company is exploring a method of its own. In the meantime, some manufacturers of flavored fish oils published pre-flavoring freshness values rather than finished product freshness values, he says.
Nordic Naturals adds that its product passed every other quality measure tested by Consumer Reports, including lead, mercury, dioxin, and polychlorinated biphenyl (PCB) testing.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.